Tag: Surveil DCB

Lower-dose SurVeil DCB achieves non-inferiority with IN.PACT Admiral balloon

 Kenneth Rosenfield (Boston, USA) speaks to Vascular News about the TRANSCEND trial, a non-inferiority randomised controlled trial, which looked to demonstrate safety and efficacy of the...
Surmodics

Surmodics completes enrolment in pivotal TRANSCEND clinical trial

Surmodics has completed enrolment in TRANSCEND, its pivotal clinical trial for the SurVeil drug-coated balloon (DCB). “TRANSCEND is a rigorous level one, randomised controlled trial...
Surmodics

12-Month data from PREVEIL study of SurVeil DCB presented at VIVA

Data from the PREVEIL early feasibility study of the SurVeil drug-coated balloon (DCB, Surmodics) were shared in a late-breaking clinical trial presentation at the...